linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth
ET Prime
Investing

Healthcare stocks are in the dumps. But Dr Lal is still earning for everyone.

The undisputed leader in the northern, central, and eastern markets is bracing up for new rivalries.
font size
FONT SIZE
save
SAVE
saved
SAVED
Gift this article
GIFT ARTICLE
anujgupta
30 Aug 2019 6 Mins Read 1 comments
(From left) Om Manchanda, CEO of Dr Lal PathLabs and Arvind Lal, chairman Getty Images
(From left) Om Manchanda, CEO of Dr Lal PathLabs and Arvind Lal, chairman
During 2005-13, WestBridge Ventures bagged a windfall from its investment in Dr Lal PathLabs (DLPL), one of India’s largest organised diagnostic chains. In 2005, the private-equity (PE) investor acquired 26.3% of DLPL at a total valuation of about USD36.5 million. However, eight years later, when it sold 15.82% of its total acquired share of about 34.14% to WestBridge Crossover Fund,
which differentiate an organised lab from a neighbourhood lab,” Dilip Bidani, group chief financial officer (CFO) of Radiant Life Care, and former CFO at DLPL, told ET Prime a few months ago. “I think there is no present threat of price caps on the diagnostic industry.” The stock market will be watching closely. ( Graphics by Mohammad Arshad)
During 2005-13, WestBridge Ventures bagged a windfall from its investment in Dr Lal PathLabs (DLPL), one of India’s largest organised diagnostic chains. In 2005, the private-equity (PE) investor acquired 26.3% of DLPL at a total valuation of about USD36.5 million. However, eight years later, when it sold 15.82% of its total acquired share of about 34.14% to WestBridge Crossover Fund, which differentiate an organised lab from a neighbourhood lab,” Dilip Bidani, group chief financial officer (CFO) of Radiant Life Care, and former CFO at DLPL, told ET Prime a few months ago. “I think there is no present threat of price caps on the diagnostic industry.” The stock market will be watching closely. ( Graphics by Mohammad Arshad)

The latest from ET Prime is now on Telegram. To subscribe to our Telegram newsletter click here.

Gift this story

YOU CAN GIFT 0 MORE STORIES THIS MONTH

Maximum 10 Email IDs allowed

300 characters remaining

Gift Sent Successfully

Limit Reached
Limit Reached

You’ve gifted all the 0 articles from your monthly gift bucket!

Please come back next month.

0 more articles will be waiting for you in your gift bucket.

CONTRIBUTORS WHO HAVE COMMENTED ON THIS STORY

test

user raja

Current Edition

An auto-industry recovery appears far away. Vehicle-carrier companies are drastically scaling down.
Logistics

An auto-industry recovery appears far away. Vehicle-carrier companies are drastically scaling down.

Automobile-transportation companies are awash in debt, with mounting losses. A key pillar of the auto-sector supply chain, many of them face an uncertain future and are selling off their prime assets – trailers and trucks for carrying cars and two-wheelers. These carriers have a chilling assessment of the ground realities. An auto-sector recovery is far, far away, they say.

headset AUDIO SUMMARY . 01:28
Maruti, Hyundai, et al. have a foggy view on demand. The way out: a tweak in the forecasting method
Automobile

Maruti, Hyundai, et al. have a foggy view on demand. The way out: a tweak in the forecasting method

Automakers will have to be more innovative in terms of demand forecasts. Use of a scenario-based forecasting methodology for the next few quarters could help. Time-series forecasts, based on historical data, won’t work in these uncertain times. Every associated element of the business — from production to sales, and logistics to component supply — needs to adopt a flexible approach.

headset AUDIO SUMMARY . 01:19
[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]